4 ms·
I had a look at your trial description (https://clinicaltrials.gov/study/NCT06424912 https://clinicaltrials.gov/study/NCT06424912) Are you planning to publish
by aquafox 1y ago
I had a look at your trial description (https://clinicaltrials.gov/study/NCT06424912 https://clinicaltrials.gov/study/NCT06424912)
Are you planning to publish the longitudinal data, esp. of endpoints 2 and 3 (prostate size, urinary flow). It would greatly add to the public understanding of this procedure. Why didn't you go for PSA? It's easy to obtain altough one probably wouldn't expect significant changes in this short time frame.
- tusharsharma09 1y agoYes, that’s the intent post study completion. We are collecting PSA data as well. It’s a useful parameter for prostate cancer.